pI: 6.7133 |
Length (AA): 402 |
MW (Da): 44844 |
Paralog Number:
0
Signal peptide: N | GPI Anchor: N | Predicted trans-membrane segments: 0
Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable
Modbase 3D models:
There are 6 models calculated for this protein. More info on
these models, including the
models themselves is available at:
Modbase
Target Beg | Target End | Template | Template Beg | Template End | Identity | Evalue | Model Score | MPQS | zDope |
---|---|---|---|---|---|---|---|---|---|
9 | 393 | 1qm4 (A) | 17 | 394 | 58.00 | 0 | 1 | 1.68 | -1.04 |
9 | 399 | 1rg9 (A) | 1 | 379 | 49.00 | 0 | 1 | 1.6 | -0.74 |
7 | 394 | 2obv (A) | 0 | 394 | 57.00 | 0 | 1 | 1.66217 | -1.06 |
8 | 401 | 3iml (A) | 2 | 387 | 50.00 | 0 | 1 | 1.4841 | -0.44 |
8 | 395 | 4ndn (A) | 15 | 395 | 59.00 | 0 | 1 | 1.66077 | -0.86 |
9 | 401 | 1p7l (A) | 1 | 381 | 48.00 | 0 | 1 | 1.52561 | -0.6 |
Help me make sense of these data.
A more detailed description of these scores is available at the Modbase Model Evaluation Help Pages, and in the papers referenced therein.
PDB Structures:
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Upper 80-100% percentile | intra-erythrocytic - 0 hs, intra-erythrocytic - 8 hs, intra-erythrocytic - 16 hs, intra-erythrocytic - 24 hs, intra-erythrocytic - 32 hs, intra-erythrocytic - 40 hs, intra-erythrocytic - 48 hs, gametocyte, merozoite, sporozoite, early ring, early schizont, early trophozoite, late ring, late schizont, late trophozoite, Oocyst, Ring, Sporozoite, Female Gametocyte. | Otto TD PlasmoDB Zanghi G Lasonder E |
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Upper 60-80% percentile | Male Gametocyte. | Lasonder E |
Zanghi G | A Specific PfEMP1 Is Expressed in P. falciparum Sporozoites and Plays a Role in Hepatocyte Infection. |
PlasmoDB | Data on upregulation of P. falciparum genes in different life cycle stages, combined from several microarray experiments available in PlasmoDB |
Lasonder E | Integrated transcriptomic and proteomic analyses of P. falciparum gametocytes. Molecular insight into sex-specific processes and translational repression. |
Otto TD | New insights into the blood-stage transcriptome of Plasmodium falciparum using RNA-Seq. |
Ortholog group members (OG5_126734)
Species | Accession | Gene Product |
---|---|---|
Arabidopsis thaliana | AT3G17390 | S-adenosylmethionine synthase 4 |
Arabidopsis thaliana | AT1G02500 | S-adenosylmethionine synthetase 1 |
Arabidopsis thaliana | AT4G01850 | S-adenosylmethionine synthase 2 |
Arabidopsis thaliana | AT2G36880 | S-adenosylmethionine synthase 3 |
Babesia bovis | BBOV_III009750 | s-adenosylmethionine synthetase, putative |
Brugia malayi | Bm1_09230 | S-adenosylmethionine synthetase |
Candida albicans | CaO19.8272 | likely S-adenosylmethionine synthetase similar to S. cerevisiae SAM2 (YDR502C) |
Candida albicans | CaO19.657 | likely S-adenosylmethionine synthetase similar to S. cerevisiae SAM2 (YDR502C) |
Caenorhabditis elegans | CELE_C06E7.3 | Protein SAMS-4, isoform B |
Caenorhabditis elegans | CELE_C06E7.1 | Protein SAMS-3, isoform C |
Caenorhabditis elegans | CELE_T13A10.11 | Protein SAMS-5, isoform B |
Caenorhabditis elegans | CELE_C49F5.1 | Protein SAMS-1 |
Cryptosporidium hominis | Chro.70301 | methionine adenosyltransferase |
Cryptosporidium parvum | cgd7_2650 | s-adenosylmethionine synthetase (SAM) |
Dictyostelium discoideum | DDB_G0291179 | S-adenosylmethionine synthetase |
Drosophila melanogaster | Dmel_CG2674 | S-adenosylmethionine Synthetase |
Escherichia coli | b2942 | S-adenosylmethionine synthetase |
Echinococcus granulosus | EgrG_000177400 | S adenosylmethionine synthase type 1 |
Entamoeba histolytica | EHI_004920 | S-adenosylmethionine synthetase, putative |
Entamoeba histolytica | EHI_195110 | S-adenosylmethionine synthetase, putative |
Entamoeba histolytica | EHI_174250 | S-adenosylmethionine synthetase, putative |
Echinococcus multilocularis | EmuJ_000177400 | S adenosylmethionine synthase type 1 |
Giardia lamblia | GL50803_5659 | S-adenosylmethionine synthetase |
Homo sapiens | ENSG00000151224 | methionine adenosyltransferase I, alpha |
Homo sapiens | ENSG00000168906 | methionine adenosyltransferase II, alpha |
Leishmania braziliensis | LbrM.30.3550 | S-adenosylmethionine synthetase |
Leishmania donovani | LdBPK_303560.1 | S-adenosylmethionine synthetase |
Leishmania infantum | LinJ.30.3580 | S-adenosylmethionine synthetase |
Leishmania infantum | LinJ.30.3560 | S-adenosylmethionine synthetase |
Leishmania major | LmjF.30.3500 | S-adenosylmethionine synthetase |
Leishmania major | LmjF.30.3520 | S-adenosylmethionine synthetase |
Leishmania mexicana | LmxM.29.3500 | S-adenosylmethionine synthetase |
Loa Loa (eye worm) | LOAG_06217 | methionine adenosyltransferase |
Mycobacterium leprae | ML0544 | Probable S-adenosylmethionine synthase MetK (MAT) (AdoMet synthetase) (Methionine adenosyltransferase) |
Mus musculus | ENSMUSG00000053907 | methionine adenosyltransferase II, alpha |
Mus musculus | ENSMUSG00000037798 | methionine adenosyltransferase I, alpha |
Mycobacterium tuberculosis | Rv1392 | Probable S-adenosylmethionine synthetase MetK (mat) (AdoMet synthetase) (methionine adenosyltransferase) |
Mycobacterium ulcerans | MUL_1791 | S-adenosylmethionine synthetase |
Neospora caninum | NCLIV_016880 | S-adenosylmethionine synthetase (EC 2.5.1.6), related |
Oryza sativa | 4337733 | Os05g0135700 |
Oryza sativa | 4325163 | Os01g0293000 |
Plasmodium berghei | PBANKA_0823100 | S-adenosylmethionine synthetase, putative |
Plasmodium falciparum | PF3D7_0922200 | S-adenosylmethionine synthetase |
Plasmodium knowlesi | PKNH_0720200 | S-adenosylmethionine synthetase, putative |
Plasmodium vivax | PVX_099525 | S-adenosylmethionine synthetase, putative |
Plasmodium yoelii | PY06246 | S-adenosylmethionine synthetase |
Saccharomyces cerevisiae | YLR180W | methionine adenosyltransferase SAM1 |
Saccharomyces cerevisiae | YDR502C | methionine adenosyltransferase SAM2 |
Schistosoma japonicum | Sjp_0215070 | ko:K00789 S-adenosylmethionine synthetase [EC2.5.1.6], putative |
Schistosoma japonicum | Sjp_0317260 | S-adenosylmethionine synthetase isoform type-1, putative |
Schistosoma mansoni | Smp_002080 | S-adenosylmethionine synthetase |
Schmidtea mediterranea | mk4.002822.01 | S-adenosylmethionine synthase |
Schmidtea mediterranea | mk4.028997.00 | |
Schmidtea mediterranea | mk4.003057.01 | S-adenosylmethionine synthase |
Schmidtea mediterranea | mk4.021769.00 | S-adenosylmethionine synthase |
Schmidtea mediterranea | mk4.002441.01 | |
Schmidtea mediterranea | mk4.016392.02 | |
Trypanosoma brucei gambiense | Tbg972.6.4700 | S-adenosylmethionine synthetase, putative |
Trypanosoma brucei gambiense | Tbg972.6.4670 | S-adenosylmethionine synthetase, putative |
Trypanosoma brucei gambiense | Tbg972.6.4690 | S-adenosylmethionine synthetase, putative |
Trypanosoma brucei gambiense | Tbg972.6.4720 | S-adenosylmethionine synthetase, putative |
Trypanosoma brucei | Tb927.6.4910 | S-adenosylmethionine synthetase, putative |
Trypanosoma brucei | Tb927.6.4890 | S-adenosylmethionine synthetase, putative |
Trypanosoma brucei | Tb927.6.4860 | S-adenosylmethionine synthetase, putative |
Trypanosoma brucei | Tb927.6.4840 | S-adenosylmethionine synthetase, putative |
Trypanosoma brucei | Tb927.6.4880 | S-adenosylmethionine synthetase, putative |
Trypanosoma brucei | Tb927.6.4920 | S-adenosylmethionine synthetase, putative |
Trypanosoma brucei | Tb927.6.4850 | S-adenosylmethionine synthetase, putative |
Trypanosoma brucei | Tb927.6.4900 | S-adenosylmethionine synthetase, putative |
Trypanosoma brucei | Tb927.6.4870 | S-adenosylmethionine synthetase, putative |
Trypanosoma congolense | TcIL3000_6_4330 | S-adenosylmethionine synthetase, putative |
Trypanosoma congolense | TcIL3000_0_37490 | S-adenosylmethionine synthetase, putative |
Trypanosoma cruzi | TcCLB.510445.50 | S-adenosylmethionine synthetase, putative |
Trypanosoma cruzi | TcCLB.506945.160 | S-adenosylmethionine synthetase, putative |
Toxoplasma gondii | TGME49_240690 | S-adenosyl methionine synthetase |
Treponema pallidum | TP0794 | S-adenosylmethionine synthetase |
Theileria parva | TP04_0893 | S-adenosylmethionine synthetase, putative |
Trichomonas vaginalis | TVAG_145700 | S-adenosylmethionine synthetase, putative |
Trichomonas vaginalis | TVAG_317070 | S-adenosylmethionine synthetase, putative |
Trichomonas vaginalis | TVAG_403830 | S-adenosylmethionine synthetase, putative |
Trichomonas vaginalis | TVAG_252200 | S-adenosylmethionine synthetase, putative |
Trichomonas vaginalis | TVAG_453040 | S-adenosylmethionine synthetase, putative |
Trichomonas vaginalis | TVAG_243700 | S-adenosylmethionine synthetase, putative |
Trichomonas vaginalis | TVAG_484900 | S-adenosylmethionine synthetase, putative |
Wolbachia endosymbiont of Brugia malayi | Wbm0699 | S-adenosylmethionine synthetase |
Gene/Ortholog | Organism | Phenotype | Source Study |
---|---|---|---|
Tb927.6.4840 | Trypanosoma brucei | no significant loss or gain of fitness in bloodstream forms (3 days) | alsford |
Tb927.6.4840 | Trypanosoma brucei | significant loss of fitness in bloodstream forms (6 days) | alsford |
Tb927.6.4840 | Trypanosoma brucei | no significant loss or gain of fitness in procyclic forms | alsford |
Tb927.6.4840 | Trypanosoma brucei | significant gain of fitness in differentiation of procyclic to bloodstream forms | alsford |
b2942 | Escherichia coli | essential | goodall |
CELE_T13A10.11 | Caenorhabditis elegans | embryonic lethal | wormbase |
CELE_T13A10.11 | Caenorhabditis elegans | larval arrest | wormbase |
CELE_T13A10.11 | Caenorhabditis elegans | larval lethal | wormbase |
CELE_T13A10.11 | Caenorhabditis elegans | slow growth | wormbase |
CELE_T13A10.11 | Caenorhabditis elegans | sterile | wormbase |
CELE_C49F5.1 | Caenorhabditis elegans | slow growth | wormbase |
CELE_C49F5.1 | Caenorhabditis elegans | sterile | wormbase |
CELE_C06E7.1 | Caenorhabditis elegans | larval arrest | wormbase |
CELE_C06E7.1 | Caenorhabditis elegans | larval lethal | wormbase |
CELE_C06E7.1 | Caenorhabditis elegans | slow growth | wormbase |
CELE_C06E7.1 | Caenorhabditis elegans | sterile | wormbase |
CELE_C06E7.3 | Caenorhabditis elegans | larval lethal | wormbase |
CELE_C06E7.3 | Caenorhabditis elegans | slow growth | wormbase |
TGME49_240690 | Toxoplasma gondii | Probably essential | sidik |
yeastgenome | Systematic deletion of yeast genes | Saccharomyces Genome Database |
wormbase | C. elegans RNAi experiments | WormBase web site, http://www.wormbase.org, release WS170 |
shigen | Profiling of E. coli Chromosome (PEC) | National Institute of Genetics, Japan |
keio | Systematic single-gene knock-out mutants of E. coli K12 | The Keio Collection |
neb | C. elegans RNAi phenotypes | Data obtained from Wormbase WS150, curated by K. Chaudary and T. Carlow, New England Biolabs |
gerdes | Experimental determination and system-level analysis of essential genes in E. coli MG1655 | Gerdes et al., J Bacteriol. 2003 185:5673-84 |
nmpdr | Genome-scale essentiality datasets from published studies (M. tuberculosis) | National Microbial Pathogen Data Resource |
alsford | High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome | Genome Res 2011, 21:915-924 |
blattner | Systematic mutagenesis of the E. coli (MG1655) genome | J Bacteriol 2004, 186:4921-4930 |
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please contact us.
Druggability index (range: 0 to 1): 0.8
Species | Known druggable target | Linked compounds | Reference |
---|---|---|---|
Rattus norvegicus | S-adenosylmethionine synthetase gamma form | Compounds | References |
Rattus norvegicus | S-adenosylmethionine synthetase alpha and beta forms | Compounds | References |
Species | Target | Length | Identity | Alignment span | Linked Drugs | Reference |
---|---|---|---|---|---|---|
Rattus norvegicus | S-adenosylmethionine synthetase (MAT 1 and MAT 2) | 395 aa | 57.4% | 390 aa | Compounds | References |
Type | Source | Notes |
---|---|---|
soluble recombinant protein | Structural Genomics for Pathogenic Protozoa (SGPP) | Pfal008828; Recombinant protein: full-length; Source: P falciparum; Methionine adenosyltransferase ; |
1 literature reference was collected for this gene.